A share price of Angiodynamic Inc [ANGO] is currently trading at $11.72, down -0.93%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ANGO shares have gain 5.21% over the last week, with a monthly amount glided 8.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Angiodynamic Inc [NASDAQ: ANGO] stock has seen the most recent analyst activity on July 16, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $24. Previously, Oppenheimer upgraded its rating to Outperform on April 05, 2024, and kept the price target unchanged to $12. On September 25, 2023, H.C. Wainwright initiated with a Buy rating and assigned a price target of $19 on the stock. Raymond James downgraded its rating to a Outperform and decreased its price target to $13 on April 17, 2023. Canaccord Genuity upgraded its rating to a Buy and raised its price target to $37 on October 15, 2021. In a note dated November 25, 2020, Raymond James upgraded an Strong Buy rating on this stock but restated the target price of $18.
Angiodynamic Inc experienced fluctuations in its stock price throughout the past year between $6.11 and $13.50. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. Angiodynamic Inc [NASDAQ: ANGO] shares were valued at $11.72 at the most recent close of the market. An investor can expect a potential return of 53.58% based on the average ANGO price forecast.
Analyzing the ANGO fundamentals
Trailing Twelve Months sales for Angiodynamic Inc [NASDAQ:ANGO] were 300.72M which represents 12.18% growth. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.11%, and Net Profit Margin reading is -0.11%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.17 and Total Capital is -0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.53 points at the first support level, and at 11.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.06, and for the 2nd resistance point, it is at 12.40.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Angiodynamic Inc [NASDAQ:ANGO] is 2.29. Also, the Quick Ratio is 1.38, while the Cash Ratio stands at 0.57. Considering the valuation of this stock, the price to sales ratio is 1.61, the price to book ratio is 2.72.
Transactions by insiders
Recent insider trading involved Trowbridge Stephen A, EVP and CFO, that happened on Oct 13 ’25 when 890.0 shares were purchased. President and CEO, Clemmer James C completed a deal on Oct 09 ’25 to buy 10000.0 shares. Meanwhile, SVP Quality and Regulatory Nighan Warren JR sold 4060.0 shares on Jan 16 ’25.
